explore -WSS

explore

author：hotspot 2025-09-28 01:39:59 - browse：3

Telehealth menopause treatment options displayed on cellphones emerging from a crack in the ground. -- health tech coverage from STAT — Molly Ferguson for STAT

At the turn of the century, nearly 18 million women in the United States were battling hot flashes, night sweats, and other symptoms of menopause with hormones. But in 2002, the therapy went into a free-fall when a landmark trial suggested treating menopause with estrogen and progesterone increased the risk of breast cancer and cardiovascular disease. The study was shut down early — and a year later, prescriptions had plummeted to nearly half what they had been in 2001.

More than two decades later, menopause experts have come to think about the results of the trial very differently. Newer research points to more benefits than risks for many healthy women under 60 treating menopause symptoms with hormone therapy. But many women who are good fits still aren’t getting treatment. “The pendulum has been slowly — too slowly — swinging back,” said OB-GYN Mike Green, chief medical officer of menopause telehealth company Winona.

Winona is part of a new generation of virtual-first health care companies aiming to give that pendulum a push. In the last five years, more than a dozen telehealth companies have started up to serve women in and approaching menopause, including with hormone therapy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： 2 million sign

focus

explore

WSS

Ambulance rides for just $100? Advisers want major billing fixes

2 million sign

FDA approves potent Eli Lilly obesity drug, Zepbound

Victims of gun violence feel impacts long after bullet wound

Search warrant issued in 1996 disappearance of Kristin Smart

A clever new way to fix Medicaid and graduate medical education

focus

explore

explore

Medical leaders decry Supreme Court decision on affirmative action

2 million sign

Wildfire smoke exposes gaps in outdoor worker protections

City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case

The cancer drug shortage isn’t new — and neither are the solutions

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Trump demands the U.S. pay no more for drugs than other countries … again

3 protesters arrested at Wimbledon after interrupting matches by throwing confetti on court

Anesthesiologist group: stop taking Ozempic before surgery

Medicare solvency divides Republicans at the presidential debate

Wikipedia

Accuser says Kevin Spacey grope wasn't a caress: ‘It was like a cobra ... angry’

'Insanity': 4th of July mass shootings across US kill 13, injure more than 80

Dramatic video released of Russian fighter jets 'harassing' US drones over Syria

FDA approves potent Eli Lilly obesity drug, Zepbound

Israel withdraws forces after 2

Condition critical? Britain's beloved but battered National Health Service turns 75

focus

explore

explore

explore